Comparative Study of Intravitreal Bevacizumab (Avastin) versus Ranibizumab (Lucentis) in the Treatment of Neovascular Age-Related Macular Degeneration

Publisher： Karger

E-ISSN： 1423-0267|223|6|370-375

ISSN： 0030-3755

Source： Ophthalmologica, Vol.223, Iss.6, 2009-07, pp. : 370-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Retinal Vessel Size Study of Intravitreal Ranibizumab and Bevacizumab in Eyes with Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 238, Iss. 3, 2017-06 ,pp. : 147-153

Karger

Access to resources Recommend Favorite

Comparing Treatment of Neovascular Age-related Macular Degeneration with Sequential Intravitreal Avastin and Macugen Versus Intravitreal Mono-therapy–A Pilot Study

By Schmid-Kubista Katharina E.   Krebs Ilse   Ansari-Shahrezaei Siamak   Haas Paulina   Hagen Stefan   Binder Susanne  

Current Eye Research, Vol. 36, Iss. 10, 2011-10 ,pp. : 958-963

Informa Healthcare

Access to resources Recommend Favorite

Switch from Intravitreal Ranibizumab to Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration: Clinical Comparison

By  

Ophthalmologica, Vol. 232, Iss. 3, 2014-08 ,pp. : 149-155

Karger

Access to resources Recommend Favorite

A Pilot Study on the Combination Treatment of Reduced-Fluence Photodynamic Therapy, Intravitreal Ranibizumab, Intravitreal Dexamethasone and Oral Minocycline for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 225, Iss. 4, 2011-02 ,pp. : 200-206

Karger

Access to resources Recommend Favorite

Does Ranibizumab (Lucentis®) Change Retrobulbar Blood Flow in Patients with Neovascular Age-Related Macular Degeneration?

By  

Ophthalmic Research, Vol. 47, Iss. 3, 2011-10 ,pp. : 141-145

Karger

Access to resources Recommend Favorite